---
title: "SK: Subsidiary Fujian Dongheng received a government subsidy of 11.445 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233422165.md"
description: "SK announced that its holding subsidiary, Fujian Dongheng New Energy Group Co., Ltd., received a government subsidy of 11.445 million yuan on March 27, 2025, which is a government subsidy related to income. This subsidy has not been audited, and the specific accounting treatment and its impact on the company's profit and loss for the year 2025 will be subject to the results confirmed after the annual audit"
datetime: "2025-03-27T09:01:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233422165.md)
  - [en](https://longbridge.com/en/news/233422165.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233422165.md)
generator: "portal-rs"
---

# SK: Subsidiary Fujian Dongheng received a government subsidy of 11.445 million yuan

SK announced that its holding subsidiary, Fujian Dongheng New Energy Group Co., Ltd., received a government subsidy of 11.445 million yuan on March 27, 2025, which is a government subsidy related to income. This subsidy is unaudited, and the specific accounting treatment and its impact on the company's profit and loss for the year 2025 will be subject to the results confirmed after the annual audit

### Related Stocks

- [688155.CN](https://longbridge.com/en/quote/688155.CN.md)

## Related News & Research

- [Hangcha Group: Revenue and profit rose over 8% year-over-year, with robust growth in new energy and global markets](https://longbridge.com/en/news/296900819.md)
- [Cattle Prices Struggle but Get Some Bullish USDA Data; Lean Hog Prices Mired at 12-Month Low](https://longbridge.com/en/news/296804867.md)
- [Saudi-listed Al Yamamah Steel unit secures $133.3mln facility from ANB](https://longbridge.com/en/news/296857306.md)
- [Rotunda-backed AirPro Diagnostics merges with ADAS workflow software firm Revv](https://longbridge.com/en/news/296822922.md)
- [EU Commission grants Lundbeck orphan drug status for asedebart in endogenous Cushing’s syndrome](https://longbridge.com/en/news/296747576.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**